{"id":303304,"date":"2026-10-13T09:04:30","date_gmt":"2026-10-13T03:34:30","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=303304"},"modified":"2026-10-15T17:35:12","modified_gmt":"2026-10-15T12:05:12","slug":"mankind-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/mankind-best-stock-in-its-sector\/","title":{"rendered":"Is Mankind Pharma the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Mankind Pharma CMP Rs 2,402 (12 Oct 2026). Market cap Rs 97,850 Cr. ROE 11.74%. P\/E 47.32x versus Industry P\/E 36.69x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Mankind Pharma is one of the names investors compare when screening the Healthcare sector, built on an 11.74% return on equity and a P\/E of 47.32x against an Industry P\/E of 36.69x. Whether Mankind Pharma is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Mankind Pharma<\/a> the best stock in its sector? The stock trades on the NSE at Rs 2,402 as of 12 October 2026, within its 52-week range of Rs 1,909.70 to Rs 2,642.00. Mankind Pharma Ltd, headquartered in New Delhi, is a pharmaceutical company selling branded generics, consumer healthcare and other products in India.<\/p>\n

Mankind Pharma sits in the Healthcare sector, and its 11.74% ROE and 47.32x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n